Offerhaus M P, Haan I B, Herijgers D C, Cools H J
Leids Universitair Medisch Centrum, Vakgroep Huisartsgeneeskunde Verpleeghuisgeneeskunde.
Tijdschr Gerontol Geriatr. 1997 Jun;28(3):101-5.
Of the 1019 residents of eight dutch homes for the elderly and 699 patients of five nursing homes, respectively 6.0 and 8.1% were administered drugs for chronic non-specific lung disease (CNSLD), which is a term covering asthma as well as copd. The treatment consisted of, usually inhaled, beta-agonists and/or anti-cholinergics in 82%, inhaled as well as oral corticosteroids in 60%, and xanthine-derivates and N-acetylcysteïne, both of which were taken orally, in 28 and 21% of the patients respectively. It was found that almost half (47%) of the patients using inhaled drugs, which 90% of them did either with or without help, made at least three mistakes during inhalation. Considering that CSNLD is probably underdiagnosed, especially when it occurs as a cause of co-morbidity and will have an unfavourable influence on the general state of health by reducing lung function, the suboptimal application of inhaled drugs should be a cause of concern for those who treat elderly patients with asthma and or copd.
在荷兰八家养老院的1019名居民和五家疗养院的699名患者中,分别有6.0%和8.1%的人使用治疗慢性非特异性肺病(CNSLD)的药物,该术语涵盖哮喘和慢性阻塞性肺病(COPD)。治疗药物通常包括82%的患者使用吸入型β受体激动剂和/或抗胆碱能药物,60%的患者使用吸入和口服皮质类固醇,分别有28%和21%的患者口服黄嘌呤衍生物和N-乙酰半胱氨酸。研究发现,近一半(47%)使用吸入药物的患者在吸入过程中至少犯了三个错误,其中90%的患者无论有无他人协助都是如此。鉴于慢性非特异性肺病可能诊断不足,尤其是当其作为合并症的病因出现时,并且会通过降低肺功能对总体健康状况产生不利影响,吸入药物的使用不当应引起治疗老年哮喘和/或慢性阻塞性肺病患者的人员的关注。